title: Muscle ring finger protein-1 inhibits PKC{epsilon} activation and prevents cardiomyocyte hypertrophy.
abstract: Much effort has focused on characterizing the signal transduction cascades that are associated with cardiac hypertrophy. In spite of this, we still know little about the mechanisms that inhibit hypertrophic growth. We define a novel anti-hypertrophic signaling pathway regulated by muscle ring finger protein-1 (MURF1) that inhibits the agonist-stimulated PKC-mediated signaling response in neonatal rat ventricular myocytes. MURF1 interacts with receptor for activated protein kinase C (RACK1) and colocalizes with RACK1 after activation with phenylephrine or PMA. Coincident with this agonist-stimulated interaction, MURF1 blocks PKCepsilon translocation to focal adhesions, which is a critical event in the hypertrophic signaling cascade. MURF1 inhibits focal adhesion formation, and the activity of downstream effector ERK1/2 is also inhibited in the presence of MURF1. MURF1 inhibits phenylephrine-induced (but not IGF-1-induced) increases in cell size. These findings establish that MURF1 is a key regulator of the PKC-dependent hypertrophic response and can blunt cardiomyocyte hypertrophy, which may have important implications in the pathophysiology of clinical cardiac hypertrophy.
authors.affiliation: Carolina Cardiovascular Biology Center, University of North Carolina, Chapel Hill, NC 27599, USA.
authors.forename: Ranjana
authors.initials: R
authors.lastname: Arya
authors.forename: Vishram
authors.initials: V
authors.lastname: Kedar
authors.forename: Jae Ryoung
authors.initials: JR
authors.lastname: Hwang
authors.forename: Holly
authors.initials: H
authors.lastname: McDonough
authors.forename: Hui-Hua
authors.initials: HH
authors.lastname: Li
authors.forename: Joan
authors.initials: J
authors.lastname: Taylor
authors.forename: Cam
authors.initials: C
authors.lastname: Patterson
mesh_terms: D000818:Animals; D019556:COS Cells; D006332:Cardiomegaly / Q000473:pathology / Q000517:prevention & control*; D048429:Cell Size / Q000187:drug effects; D002522:Chlorocebus aethiops; D022001:Focal Adhesions / Q000187:drug effects / Q000378:metabolism; D009124:Muscle Proteins; D032383:Myocytes, Cardiac / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D010455:Peptides / Q000378:metabolism; D010656:Phenylephrine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D011493:Protein Kinase C / Q000037:antagonists & inhibitors* / Q000378:metabolism; D051744:Protein Kinase C-epsilon; D051381:Rats; D000075370:Receptors for Activated C Kinase; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology; D000070584:Tripartite Motif Proteins; D044767:Ubiquitin-Protein Ligases / Q000235:genetics / Q000494:pharmacology / Q000502:physiology*
chemical_list: D009124:Muscle Proteins; D010455:Peptides; D000075370:Receptors for Activated C Kinase; D000070584:Tripartite Motif Proteins; C070301:peptide I; D010656:Phenylephrine; C440908:TRIM63 protein, human; C499086:Trim63 protein, rat; D044767:Ubiquitin-Protein Ligases; C497257:Prkce protein, rat; D011493:Protein Kinase C; D051744:Protein Kinase C-epsilon